Long-term follow-up of a phase 3 clinical trial of inolimomab for the treatment of primary steroid refractory aGVHD

Autor: Socié, Gérard ^*, Milpied, Noel, Yakoub-Agha, Ibrahim, Bay, Jacques-Olivier, Fürst, Sabine, Bilger, Karin, Suarez, Felipe, Michallet, Mauricette, Lewalle, Philippe, Liens, David, Mathis, Catherine, Guemas, Eric, Vernant, Jean-Paul

Publikováno v: In Blood Advances 22 January 2019 3(2):184-186

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

L-Asparaginase-Loaded Red Blood Cells Combined with Standard EWALL Chemotherapy in Older Patients with Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia (Ph- ALL): First Results of the GRASPALL/GRAALL-SA2-2008 Study

Autor: Hunault, Mathilde ^*, Legay, Thibault ^*, Huguet, Françoise ^*, Leprêtre, Stéphane ^*, Deconinck, Eric, Uribe, Mario Ojeda ^*, Bonmati, Caroline ^*, Lioure, Bruno ^*, Himberlin, Catherine ^*, Chevallier, Patrice ^*, Rousselot, Philippe ^*, Reman, Oumedaly, Boulland, Marie-Laure ^*, Lhéritier, Véronique ^*, Lissandre, Severine ^*, Turlure, Pascal ^*, Bouscary, Didier ^*, Sanhes, Laurence ^*, Legrand, Ollivier ^*, Plantier, Isabelle ^*, Piocelle, Frédérique Orsini ^*, Liens, David, Godfrin, Yann, Ifrah, Norbert, Dombret, Herve

Publikováno v: In Blood 18 November 2011 118(21):2579-2579

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A Phase 2 study of L-asparaginase encapsulated in erythrocytes in elderly patients with Philadelphia chromosome negative acute lymphoblastic leukemia: The GRASPALL/GRAALL-SA2-2008 study.

Autor: Hunault-Berger M; Haematology Department of Angers, Angers, France., Leguay T; Haematology Department of Bordeaux, Bordeaux, France., Huguet F; Haematology Department of Toulouse, Toulouse, France., Leprêtre S; Haematology Department of Rouen, Rouen, France., Deconinck E; Haematology Department of Besançon, Besançon, France., Ojeda-Uribe M; Haematology Department of Mulhouse, Mulhouse, France., Bonmati C; Haematology Department of Nancy, Nancy, France., Escoffre-Barbe M; Haematology Department of Rennes, Rennes, France., Bories P; Haematology Department of Strasbourg, Strasbourg, France., Himberlin C; Haematology Department of Reims, Reims, France., Chevallier P; Haematology Department of Nantes, Nantes, France., Rousselot P; Haematology Department of Versailles, Versailles, France., Reman O; Haematology Department of Caen, Caen, France., Boulland ML; Haematology Department of Rennes, Rennes, France., Lissandre S; Haematology Department of Tours, Tours, France., Turlure P; Haematology Department of Limoges, Limoges, France., Bouscary D; Haematology Department of Cochin APHP Paris, France., Sanhes L; Haematology Department of Perpignan, Perpignan, France., Legrand O; Haematology Department of Saint Antoine APHP Paris, France., Lafage-Pochitaloff M; Genetic Department of AP-HM Marseille, France., Béné MC; Haematology Department of Nantes, Nantes, France., Liens D; Haematology Department of ERYTECH Pharma, France., Godfrin Y; Haematology Department of ERYTECH Pharma, France., Ifrah N; Haematology Department of Angers, Angers, France., Dombret H; Haematology Department of Saint-Louis AP-HP Paris, France.

Publikováno v: American journal of hematology [Am J Hematol] 2015 Sep; Vol. 90 (9), pp. 811-8.